stockportfolio.pro
ACADIA Pharmaceuticals Inc. Revenue 2009–2025
ACADIA Pharmaceuticals Inc. (ACAD) annual revenue by fiscal year, computed from SEC filings. Compound growth +37.7%/yr over 16 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $1.07B | +11.9% |
| FY 2024 | $957.80M | +31.8% |
| FY 2023 | $726.44M | +40.4% |
| FY 2022 | $517.24M | +6.8% |
| FY 2021 | $484.14M | +9.6% |
| FY 2020 | $441.75M | +30.3% |
| FY 2019 | $339.08M | +51.5% |
| FY 2018 | $223.81M | +79.2% |
| FY 2017 | $124.90M | +620.7% |
| FY 2016 | $17.33M | +28311.5% |
| FY 2015 | $61,000 | -49.2% |
| FY 2014 | $120,000 | -89.5% |
| FY 2013 | $1.15M | -76.7% |
| FY 2012 | $4.91M | +137.4% |
| FY 2011 | $2.07M | -95.1% |
| FY 2010 | $42.13M | +558.5% |
| FY 2009 | $6.40M | — |
Source: ACADIA Pharmaceuticals Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for ACADIA Pharmaceuticals Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeACADIA Pharmaceuticals Inc. — frequently asked questions
What is ACADIA Pharmaceuticals Inc.'s revenue?
ACADIA Pharmaceuticals Inc. (ACAD) reported revenue of $1.07B for fiscal year 2025, per its SEC filings.
How has ACADIA Pharmaceuticals Inc.'s revenue changed over time?
Between fiscal 2009 and 2025, ACAD's revenue grew at roughly 37.7% per year (compound annual rate), from $6.40M to $1.07B.
Where does this data come from?
Figures are computed from ACADIA Pharmaceuticals Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.